{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,28]],"date-time":"2026-10-28T08:21:13Z","timestamp":1793175673178,"version":"4.5.0"},"reference-count":27,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,10,24]],"date-time":"2024-10-24T00:00:00Z","timestamp":1729728000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2024,10,24]],"date-time":"2024-10-24T00:00:00Z","timestamp":1729728000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/100000025","name":"U.S. National Institute of Mental Health","doi-asserted-by":"crossref","award":["R01 MH113572"],"award-info":[{"award-number":["R01 MH113572"]}],"id":[{"id":"10.13039\/100000025","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100000025","name":"U.S. National Institute of Mental Health","doi-asserted-by":"crossref","award":["R01 MH113572"],"award-info":[{"award-number":["R01 MH113572"]}],"id":[{"id":"10.13039\/100000025","id-type":"DOI","asserted-by":"crossref"}]},{"name":"U.S. National Institutes of Mental Health","award":["R00 MH121166"],"award-info":[{"award-number":["R00 MH121166"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Health Serv Res"],"DOI":"10.1186\/s12913-024-11521-y","type":"journal-article","created":{"date-parts":[[2024,10,24]],"date-time":"2024-10-24T16:03:32Z","timestamp":1729785812000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Acceptability of six-monthly PrEP dispensing supported with interim HIV self-testing to simplify PrEP delivery in Kenya: findings from qualitative research"],"prefix":"10.1186","volume":"24","author":[{"given":"Nicholas","family":"Thuo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ashley R.","family":"Bardon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Mogere","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Catherine","family":"Kiptinness","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edinah","family":"Casmir","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Njeri","family":"Wairimu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emmah","family":"Owidi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Phelix","family":"Okello","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nelly R.","family":"Mugo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jared M.","family":"Baeten","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kenneth","family":"Ngure","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katrina F.","family":"Ortblad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,10,24]]},"reference":[{"issue":"12","key":"11521_CR1","doi-asserted-by":"publisher","first-page":"1973","DOI":"10.1097\/QAD.0000000000001145","volume":"30","author":"VA Fonner","year":"2016","unstructured":"Fonner VA, Dalglish SL, Kennedy CE, Baggaley R, O\u2019Reilly KR, Koechlin FM, et al. Effectiveness and safety of oral HIV preexposure prophylaxis for all populations. AIDS. 2016;30(12):1973.","journal-title":"AIDS"},{"key":"#cr-split#-11521_CR2.1","unstructured":"AIDS Vaccine Advocacy Coalition. PrEP Watch: Country Overview: Kenya 2023 [Internet]. New York (US): AVAC"},{"key":"#cr-split#-11521_CR2.2","unstructured":"2022 [cited 2022 Nov 1]. https:\/\/www.prepwatch.org\/countries\/kenya\/"},{"issue":"12","key":"11521_CR3","doi-asserted-by":"publisher","first-page":"e1730","DOI":"10.1016\/S2214-109X(21)00391-0","volume":"9","author":"EM Irungu","year":"2021","unstructured":"Irungu EM, Mugwanya KK, Mugo NR, Bukusi EA, Donnell D, Odoyo J, et al. Integration of pre-exposure prophylaxis services into public HIV care clinics in Kenya: a pragmatic stepped-wedge randomised trial. Lancet Glob Health. 2021;9(12):e1730\u20139.","journal-title":"Lancet Glob Health"},{"issue":"1","key":"11521_CR4","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1097\/COH.0000000000000224","volume":"11","author":"NR Mugo","year":"2016","unstructured":"Mugo NR, Ngure K, Kiragu M, Irungu E, Kilonzo N. The preexposure prophylaxis revolution; from clinical trials to programmatic implementation. Curr Opin HIV AIDS. 2016;11(1):80\u20136.","journal-title":"Curr Opin HIV AIDS"},{"issue":"3","key":"11521_CR5","doi-asserted-by":"publisher","first-page":"e1001401","DOI":"10.1371\/journal.pmed.1001401","volume":"10","author":"GB Gomez","year":"2013","unstructured":"Gomez GB, Borquez A, Case KK, Wheelock A, Vassall A, Hankins C. The cost and impact of scaling up pre-exposure prophylaxis for HIV prevention: a systematic review of cost-effectiveness modelling studies. PLoS Med. 2013;10(3):e1001401.","journal-title":"PLoS Med"},{"key":"11521_CR6","unstructured":"National AIDS, STI Control Program (NASCOP). &. Guidelines on Use of Antiretroviral Drugs for Treating and Preventing HIV Infection in Kenya [Internet]. Nairobi (KE): NASCOP; 2016 [cited 2024 August 8]. https:\/\/www.prepwatch.org\/wp-content\/uploads\/2016\/08\/Guidelines-on-ARV-for-Treating-Preventing-HIV-Infections-in-Kenya.pdf"},{"key":"11521_CR7","unstructured":"National AIDS, STI Control Program (NASCOP). &. Differentiated Care: Operational Guide [Internet]. Nairobi (KE): NASCOP; 2017 [cited 2022 Nov 1]. http:\/\/cquin.icap.columbia.edu\/wp-content\/uploads\/2017\/04\/ICAP_CQUIN_DC-operational-guide_NASCOP_2017.pdf"},{"issue":"12","key":"11521_CR8","doi-asserted-by":"publisher","first-page":"1477","DOI":"10.1080\/09540121.2018.1500995","volume":"30","author":"JM Hagey","year":"2018","unstructured":"Hagey JM, Li X, Barr-Walker J, Penner J, Kadima J, Oyaro P, et al. Differentiated HIV care in sub-saharan Africa: a scoping review to inform antiretroviral therapy provision for stable HIV-infected individuals in Kenya. AIDS Care. 2018;30(12):1477\u201387.","journal-title":"AIDS Care"},{"key":"11521_CR9","unstructured":"World Health Organization. WHO recommends HIV self-testing \u2013 evidence update and considerations for success [Internet]. Geneva (CH): WHO. 2019. [cited 2022 Nov 1]. https:\/\/www.who.int\/publications\/i\/item\/WHO-CDS-HIV-19.36"},{"issue":"7","key":"11521_CR10","doi-asserted-by":"publisher","first-page":"e464","DOI":"10.1016\/S2352-3018(22)00126-6","volume":"9","author":"K Ngure","year":"2022","unstructured":"Ngure K, Ortblad KF, Mogere P, Bardon AR, Thomas KK, Mangale D, et al. Efficiency of 6-month PrEP dispensing with HIV self-testing in Kenya: an open-label, randomised, non-inferiority, implementation trial. Lancet HIV. 2022;9(7):e464\u201373.","journal-title":"Lancet HIV"},{"issue":"6","key":"11521_CR11","doi-asserted-by":"publisher","first-page":"e2318590","DOI":"10.1001\/jamanetworkopen.2023.18590","volume":"6","author":"KF Ortblad","year":"2023","unstructured":"Ortblad KF, Bardon AR, Mogere P, Kiptinness C, Gakuo S, Mbaire S, et al. Effect of 6-Month HIV Preexposure Prophylaxis dispensing with interim self-testing on Preexposure Prophylaxis Continuation at 12 months: a Randomized Noninferiority Trial. JAMA Netw Open. 2023;6(6):e2318590\u2013e.","journal-title":"JAMA Netw Open"},{"issue":"4","key":"11521_CR12","doi-asserted-by":"publisher","first-page":"591","DOI":"10.1177\/1049732316665344","volume":"27","author":"MM Hennink","year":"2017","unstructured":"Hennink MM, Kaiser BN, Marconi VC. Code saturation versus meaning saturation: how many interviews are enough? Qual Health Res. 2017;27(4):591\u2013608.","journal-title":"Qual Health Res"},{"issue":"1","key":"11521_CR13","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1177\/1525822X05279903","volume":"18","author":"G Guest","year":"2006","unstructured":"Guest G, Bunce A, Johnson L. How many interviews are enough? An experiment with data saturation and variability. Field Methods. 2006;18(1):59\u201382.","journal-title":"Field Methods"},{"issue":"9","key":"11521_CR14","doi-asserted-by":"publisher","first-page":"606","DOI":"10.1046\/j.1525-1497.2001.016009606.x","volume":"16","author":"K Kroenke","year":"2001","unstructured":"Kroenke K, Spitzer RL, Williams JB. The PHQ-9: validity of a brief depression severity measure. J Gen Intern Med. 2001;16(9):606\u201313.","journal-title":"J Gen Intern Med"},{"key":"11521_CR15","volume-title":"Measures in health psychology: a user\u2019s portfolio","author":"R Schwarzer","year":"1995","unstructured":"Schwarzer R, Jerusalem M, Weinman J, Wright S, Johnston M. Measures in health psychology: a user\u2019s portfolio. London (GB): nferNelson; 1995."},{"issue":"1","key":"11521_CR16","doi-asserted-by":"publisher","first-page":"160940691773384","DOI":"10.1177\/1609406917733847","volume":"16","author":"LS Nowell","year":"2017","unstructured":"Nowell LS, Norris JM, White DE, Moules NJ. Thematic analysis: striving to meet the trustworthiness criteria. Int J Qual Methods. 2017;16(1):1609406917733847.","journal-title":"Int J Qual Methods"},{"issue":"1","key":"11521_CR17","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1186\/s12913-017-2031-8","volume":"17","author":"M Sekhon","year":"2017","unstructured":"Sekhon M, Cartwright M, Francis JJ. Acceptability of healthcare interventions: an overview of reviews and development of a theoretical framework. BMC Health Serv Res. 2017;17(1):88.","journal-title":"BMC Health Serv Res"},{"issue":"1","key":"11521_CR18","doi-asserted-by":"publisher","first-page":"101037","DOI":"10.1016\/j.bjid.2020.11.002","volume":"25","author":"B Hoagland","year":"2021","unstructured":"Hoagland B, Torres TS, Bezerra DRB, Benedetti M, Pimenta C, Veloso VG, et al. High acceptability of PrEP teleconsultation and HIV self-testing among PrEP users during the COVID-19 pandemic in Brazil. Braz J Infect Dis. 2021;25(1):101037.","journal-title":"Braz J Infect Dis"},{"issue":"1","key":"11521_CR19","doi-asserted-by":"publisher","first-page":"503","DOI":"10.1186\/s12879-018-3415-z","volume":"18","author":"KF Ortblad","year":"2018","unstructured":"Ortblad KF, Chanda MM, Musoke DK, Ngabirano T, Mwale M, Nakitende A, et al. Acceptability of HIV self-testing to support pre-exposure prophylaxis among female sex workers in Uganda and Zambia: results from two randomized controlled trials. BMC Infect Dis. 2018;18(1):503.","journal-title":"BMC Infect Dis"},{"key":"11521_CR20","doi-asserted-by":"crossref","unstructured":"Kiptinness C, Kuo AP, Reedy AM, Johnson CC, Ngure K, Wagner AD et al. Examining the Use of HIV Self-Testing to support PrEP delivery: a systematic literature review. Curr HIV\/AIDS Rep. 2022:1\u201315.","DOI":"10.1007\/s11904-022-00617-x"},{"issue":"1","key":"11521_CR21","doi-asserted-by":"publisher","first-page":"18","DOI":"10.9745\/GHSP-D-19-00286","volume":"8","author":"J Hubbard","year":"2020","unstructured":"Hubbard J, Phiri K, Moucheraud C, McBride K, Bardon A, Balakasi K, et al. A qualitative Assessment of Provider and Client experiences with 3- and 6-Month dispensing intervals of antiretroviral therapy in Malawi. Glob Health Sci Prac. 2020;8(1):18\u201327.","journal-title":"Glob Health Sci Prac"},{"issue":"4","key":"11521_CR22","doi-asserted-by":"publisher","first-page":"541","DOI":"10.1080\/09540121.2020.1755010","volume":"33","author":"K Phiri","year":"2021","unstructured":"Phiri K, McBride K, Siwale Z, Hubbard J, Bardon A, Moucheraud C, et al. Provider experiences with three-and six-month antiretroviral therapy dispensing for stable clients in Zambia. AIDS Care. 2021;33(4):541\u20137.","journal-title":"AIDS Care"},{"key":"11521_CR23","doi-asserted-by":"publisher","first-page":"453","DOI":"10.3389\/fpubh.2023.1054559","volume":"11","author":"C Kiptinness","year":"2023","unstructured":"Kiptinness C, Naik P, Thuo N, Malen RC, Dettinger JC, Pintye J, et al. Online HIV prophylaxis delivery: protocol for the ePrEP Kenya pilot study. Front Public Health. 2023;11:453.","journal-title":"Front Public Health"},{"key":"11521_CR24","unstructured":"Watoyi S, Urden J, Akim E, Abuna F, Nyabiage J, Unger JA et al. Engagement with an interactive adherence text messaging platform among women initiating PrEP during pregnancy in Kenya: the Mobile WACh-PrEP Study. Poster presentation at Continuum 2024, Puerto Rico, June 9\u201311, 2024. Abstract 1200."},{"issue":"11","key":"11521_CR25","doi-asserted-by":"publisher","first-page":"3755","DOI":"10.1007\/s10461-023-04093-1","volume":"27","author":"M Henderson","year":"2023","unstructured":"Henderson M, Schmidt H-MA, Chitembo L, Peralta H, Alaama AS, Johnson C, et al. The future of pre-exposure prophylaxis (PrEP) for HIV prevention: a global qualitative consultation on provider perspectives on new products and differentiated service delivery. AIDS Behav. 2023;27(11):3755\u201366.","journal-title":"AIDS Behav"},{"key":"11521_CR26","unstructured":"World Health Organization. Differentiated and simplified pre-exposure prophylaxis for HIV prevention: update to WHO implementation guidance [Internet]. Geneva (CH): WHO; 2022. [cited 2022 Nov 1]. https:\/\/www.who.int\/publications\/i\/item\/9789240053694"}],"container-title":["BMC Health Services Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12913-024-11521-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12913-024-11521-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12913-024-11521-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,10,24]],"date-time":"2024-10-24T16:04:19Z","timestamp":1729785859000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmchealthservres.biomedcentral.com\/articles\/10.1186\/s12913-024-11521-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,10,24]]},"references-count":27,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["11521"],"URL":"https:\/\/doi.org\/10.1186\/s12913-024-11521-y","relation":{},"ISSN":["1472-6963"],"issn-type":[{"value":"1472-6963","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,10,24]]},"assertion":[{"value":"14 May 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 September 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 October 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This research involved human subjects. The research protocol, including all study procedures, was approved by ethics review boards in both the United States (Fred Hutchinson Cancer Center) and Kenya (Scientific Ethics Review Unit, Kenya Medical Research Institute). All eligible participants were enrolled by trained research staff, provided written informed consent, and received 300 KES (~$3 USD) as compensation for their time completing research activities.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"JMB is an employee of Gilead Sciences, and PM is an employee of Novartis Pharmaceuticals, both outside this scope of work. For the remaining authors, no competing interests were declared.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"1281"}}